Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma.
Saved in:
| Title: | Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma. |
|---|---|
| Authors: | Chehrazi-Raffle, Alexander1 (AUTHOR), Muddasani, Ramya1 (AUTHOR), Dizman, Nazli1 (AUTHOR), Hsu, JoAnn1 (AUTHOR), Meza, Luis1 (AUTHOR), Zengin, Zeynep B.1 (AUTHOR), Malhotra, Jasnoor1 (AUTHOR), Chawla, Neal1 (AUTHOR), Dorff, Tanya1 (AUTHOR), Contente-Cuomo, Tania2 (AUTHOR), Dinwiddie, Devin2 (AUTHOR), McDonald, Bradon R.3 (AUTHOR), McDaniel, Timothy2 (AUTHOR), Trent, Jeffrey M.2 (AUTHOR), Baehner, Frederick L.4 (AUTHOR), Murtaza, Muhammed2,3 (AUTHOR), Pal, Sumanta K.1 (AUTHOR) spal@coh.org |
| Source: | JCO Precision Oncology. 4/30/2023, p1-9. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 24734284 |
|---|---|
| DOI: | 10.1200/PO.22.00543 |
